EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC 4.0

Barriers to discontinuing benzodiazepine receptor agonists in older adults: a survey of older adults across Europe

Vladyslav Shapoval iD, Marie de Saint Hubert, Catherine Pétein, Claire Viaud, Tokandji Adda, Carole Elodie Aubert iD, Blandine Mooser, Vagioula Tsoutsi, Dimitris Dikeos, Laura Fernández Maldonado, Joan Manuel Perez Castejon, Adam Wichniak und 9 weitere

Age and Ageing · 2025

DOI: 10.1093/ageing/afaf342 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Age and Ageing, 2025. Verfasst von Vladyslav Shapoval und 20 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium. Hauptthemen laut MEDLINE: GABA-A Receptor Agonists, Health Knowledge, Attitudes, Practice, Sleep, Sleep Wake Disorders. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Various factors hinder older adults from discontinuing benzodiazepine receptor agonists (BZRAs). Identifying and prioritising these barriers is essential for designing effective interventions to discontinue BZRAs.

Objective

To identify barriers to BZRA discontinuation among older adults and factors associated with their willingness to reduce or stop use.

Methods

A cross-sectional survey was conducted among adults 65+ using BZRA for sleep problems, recruited from hospitals across six European countries. Barriers were identified via a 27-item questionnaire grounded in the Theoretical Domains Framework (TDF), which systematically identifies individual and contextual determinants of behaviour. Responses were analysed using descriptive statistics. Multivariable logistic regressions identified factors associated with patients’ willingness to reduce or stop BZRA.

Results

Among 183 participants, 59.1% were willing to reduce and 42.7% to stop BZRA if recommended by their doctor. Half understood why discontinuation is necessary. Barriers were present for most participants across multiple TDF domains. They included: high satisfaction with BZRA, perceived low risk of side effects, limited coping skills or ability to stop, fear of discontinuation and lack of support from physicians or social networks. Higher scores in the TDF domains of Goals, Emotion and Social Influences were associated with greater willingness to reduce BZRA. These domains and Reinforcement, Environmental context and resources were also linked to a greater willingness to stop.

Conclusions

These findings highlight the opportunities and challenges of discontinuing BZRA in older adults. While half know the need to discontinue and are willing to try, future interventions must address pervasive barriers across many behavioural domains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GABA-A Receptor AgonistsHealth Knowledge, Attitudes, PracticeSleepSleep Wake DisordersAgedAged, 80 and overFemaleHumansMaleAdaptation, PsychologicalAge FactorsCross-Sectional StudiesEuropeSurveys and Questionnaires

Stichwörter der Autor:innen

benzodiazepinesdeprescribingmedication safetyolder adultsz-drugs

Substanzen

GABA-A Receptor Agonists

Autor:innen und Institutionen

  • Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium.
  • Department of Geriatric Medicine, CHU UCL Namur, Yvoir, Belgium.
  • Institute of Health and Society (IRSS), Université Catholique de Louvain, Brussels, Belgium.
  • Pharmacy Department, CHU UCL Namur, Yvoir, Belgium.
  • Department of General Internal Medicine, Inselspital University Hospital Bern, Bern, Switzerland.
  • Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.

ORCID-Profile: Vladyslav Shapoval, Carole Elodie Aubert, Jeremy Grimshaw, Justin Presseau, Séverine Henrard

Zitieren

APA

Shapoval, V., de Saint Hubert, M., Pétein, C., Viaud, C., Adda, T., Aubert, C. E., Mooser, B., Tsoutsi, V., Dikeos, D., Maldonado, L. F., Castejon, J. M. P., Wichniak, A., Gustavsson, K., Wyller, T. B., Callegari, E., Grimshaw, J., Presseau, J., Patey, A., Corachan, S., …, & Spinewine, A. (2025). Barriers to discontinuing benzodiazepine receptor agonists in older adults: a survey of older adults across Europe. Age and Ageing. https://doi.org/10.1093/ageing/afaf342

Vancouver

Shapoval V, de Saint Hubert M, Pétein C, Viaud C, Adda T, Aubert CE, et al. Barriers to discontinuing benzodiazepine receptor agonists in older adults: a survey of older adults across Europe. Age and Ageing. 2025. doi:10.1093/ageing/afaf342

BibTeX
@article{Shapoval2025,
  author = {Shapoval, Vladyslav and de Saint Hubert, Marie and Pétein, Catherine and Viaud, Claire and Adda, Tokandji and Aubert, Carole Elodie and Mooser, Blandine and Tsoutsi, Vagioula and Dikeos, Dimitris and Maldonado, Laura Fernández and Castejon, Joan Manuel Perez and Wichniak, Adam and Gustavsson, Katarzyna and Wyller, Torgeir Bruun and Callegari, Enrico and Grimshaw, Jeremy and Presseau, Justin and Patey, Andrea and Corachan, Sabine and Henrard, Séverine and Spinewine, Anne},
  title = {Barriers to discontinuing benzodiazepine receptor agonists in older adults: a survey of older adults across Europe},
  journal = {Age and Ageing},
  year = {2025},
  doi = {10.1093/ageing/afaf342}
}
Kostenlos starten →